Moderna
MRNA
#1057
Rank
HK$172.95 B
Marketcap
HK$437.94
Share price
1.80%
Change (1 day)
66.94%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of September 2025 : HK$73.00 Billion

According to Moderna 's latest financial reports the company has HK$73.00 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$84.62 B-21.78%
2023-12-31$HK$108.20 B-27.58%
2022-12-31$HK$149.41 B35.46%
2021-12-31$HK$110.29 B455.56%
2020-12-31$HK$19.85 B116.99%
2019-12-31$HK$9.14 B-23.65%
2018-12-31$HK$11.98 B145.28%
2017-12-31$HK$4.88 B-25.16%
2016-12-31$HK$6.52 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
HK$638.04 B 774.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$364.22 B 398.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$406.14 B 456.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$0.54 B-99.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$0.29 Billion-100.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$6.17 B-91.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$4.40 B-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA